Skip to content

Frontlight ResearchEarly access

Trial site

Pa0012 50034

Rochester, New York 14642, United StatesNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Psoriasis
Psoriatic arthritis

Closed trials

Completed
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
NCT04009499· Phase 3· UCB Biopharma SRL· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Pa0012 50034: trial site – Frontlight Research